For: | Chen P, Fang QX, Chen DB, Chen HS. Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma. World J Gastrointest Oncol 2021; 13(7): 673-683 [PMID: 34322196 DOI: 10.4251/wjgo.v13.i7.673] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v13/i7/673.htm |
Number | Citing Articles |
1 |
Junze Liang, Yanxia Liao, Zhiwei Tu, Jinping Liu. Revamping Hepatocellular Carcinoma Immunotherapy: The Advent of Microbial Neoantigen Vaccines. Vaccines 2024; 12(8): 930 doi: 10.3390/vaccines12080930
|
2 |
Ben L. Da, Aiwu Ruth He, Kirti Shetty, Kelly I. Suchman, Herbert Yu, Lawrence Lau, Linda L. Wong, Atoosa Rabiee, Richard L. Amdur, James M. Crawford, Sharon S. Fox, Gregory M. Grimaldi, Priya K. Shah, Jonathan Weinstein, David Bernstein, Sanjaya K. Satapathy, Nyasha Chambwe, Xiyan Xiang, Lopa Mishra. Pathogenesis to management of hepatocellular carcinoma. Genes & Cancer 2022; 13: 72 doi: 10.18632/genesandcancer.226
|
3 |
Pu Chen, Dongbo Chen, Dechao Bu, Jie Gao, Wanying Qin, Kangjian Deng, Liying Ren, Shaoping She, Wentao Xu, Yao Yang, Xingwang Xie, Weijia Liao, Hongsong Chen. Dominant neoantigen verification in hepatocellular carcinoma by a single-plasmid system coexpressing patient HLA and antigen. Journal for ImmunoTherapy of Cancer 2023; 11(4): e006334 doi: 10.1136/jitc-2022-006334
|
4 |
Sumit Roy, Vancha Harish, Sharfuddin Mohd, Sachin Kumar Singh. Breaking Down the Arsenal: Recent Progress in the Nanotherapeutic Strategies for Hepatocellular Carcinoma Treatment. Advanced Therapeutics 2024; doi: 10.1002/adtp.202400126
|
5 |
Jenni Viivi Linnea Niemi, Aleksandr V. Sokolov, Helgi B. Schiöth. Neoantigen Vaccines; Clinical Trials, Classes, Indications, Adjuvants and Combinatorial Treatments. Cancers 2022; 14(20): 5163 doi: 10.3390/cancers14205163
|
6 |
Amir Ghaffari Jolfayi, Zahra Taheri, Soroush Khojasteh-Kaffash, Seyedeh Zahra Hosseini Imani, Fatemeh Afra, Zohreh Tajabadi, Gita Manzari Tavakoli, Nima Rezaei. Handbook of Cancer and Immunology. 2024; : 1 doi: 10.1007/978-3-030-80962-1_404-1
|
7 |
Tzy Harn Chua, Lavisha S Punjabi, Li Yan Khor. Tissue Pathogens and Cancers: A Review of Commonly Seen Manifestations in Histo- and Cytopathology. Pathogens 2021; 10(11): 1410 doi: 10.3390/pathogens10111410
|
8 |
Yi-Fei Li, Qiong-Qiong Hou, Shuang Zhao, Xiaoyan Chen, Min Tang, Lin Li. Identification of tumor-specific neoantigens and immune clusters of hepatocellular carcinoma for mRNA vaccine development. Journal of Cancer Research and Clinical Oncology 2023; 149(2): 623 doi: 10.1007/s00432-022-04285-7
|
9 |
David Repáraz, Belén Aparicio, Diana Llopiz, Sandra Hervás-Stubbs, Pablo Sarobe. Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?. International Journal of Molecular Sciences 2022; 23(4): 2022 doi: 10.3390/ijms23042022
|
10 |
Seokhwan Chung, Chan Mi Lee, Miqin Zhang. Advances in nanoparticle-based mRNA delivery for liver cancer and liver-associated infectious diseases. Nanoscale Horizons 2023; 8(1): 10 doi: 10.1039/D2NH00289B
|
11 |
M. V. Dmitrieva, M. A. Baryshnikovа, O. L. Orlova, V. S. Kosorukov. Technological aspects of creating neopeptide vaccines. Russian Journal of Biotherapy 2022; 21(4): 10 doi: 10.17650/1726-9784-2022-21-4-10-21
|
12 |
Nadine Soliman, Ashish Saharia, Maen Abdelrahim, Ashton A. Connor. Molecular profiling in the management of hepatocellular carcinoma. Current Opinion in Organ Transplantation 2024; 29(1): 10 doi: 10.1097/MOT.0000000000001124
|
13 |
Lisabeth Emilius, Franziska Bremm, Amanda Katharina Binder, Niels Schaft, Jan Dörrie. Tumor Antigens beyond the Human Exome. International Journal of Molecular Sciences 2024; 25(9): 4673 doi: 10.3390/ijms25094673
|